Overview and definition
This article addresses two distinct neurogenic entities that may present in the oral and maxillofacial region: traumatic neuroma and ganglioneuroma. Despite sharing the "neuroma" designation, they differ fundamentally in biology.
- Traumatic neuroma is a reactive, non-neoplastic proliferation of nerve tissue resulting from injury to a peripheral nerve. It represents a hyperplastic reparative response in which regenerating axons, Schwann cells, and fibrous tissue form a disorganized nodular mass at the site of nerve disruption. In the oral region, the most common etiologic factor is tooth extraction, though any surgical or accidental trauma to branches of the trigeminal nerve may be causative. The majority of oral traumatic neuromas are extraosseous soft-tissue nodules; intraosseous lesions are uncommon. On imaging, intraosseous traumatic neuromas characteristically appear as radiolucent lesions associated with the inferior alveolar nerve canal. Management is excisional biopsy, with excellent prognosis and low recurrence.[1][2][3]
- Ganglioneuroma is a benign, fully differentiated neoplasm of neural crest origin, classified within the peripheral neuroblastic tumor group (WHO ICD-O code 9490/0). It arises from the autonomic sympathetic nervous system and is composed of mature ganglion cells within Schwannian stroma. Ganglioneuroma is exceedingly rare in the jaws, with only a handful of mandibular cases reported. Management is surgical excision, with excellent prognosis.[4][5][6][7][8]
Terminology and classification
Traumatic neuroma
- The accepted term is traumatic neuroma (also amputation neuroma or stump neuroma). It is classified as a tumor-like, non-neoplastic reactive process rather than a true neoplasm.[1][9][10]
- When mature ganglion cells are present within a traumatic neuroma, the term pseudoganglioneuroma has been applied to distinguish this reactive lesion from true ganglioneuroma. This distinction is clinically important because pseudoganglioneuromas are non-neoplastic and require no further treatment beyond excision.[11]
Ganglioneuroma
- Ganglioneuroma is the current WHO-accepted term (5th edition, 2023) for the most mature, benign end of the peripheral neuroblastic tumor spectrum. It is classified as Schwannian stroma-dominant.[4]
- Ganglioneuroma is distinct from ganglioneuroblastoma (intermixed or nodular subtypes), which contain immature neuroblastic elements and carry different biologic behavior.[4][5]
Epidemiology
Traumatic neuroma
- Oral traumatic neuromas are uncommon, representing approximately 0.09% of oral and maxillofacial biopsy specimens in large retrospective series.[12]
- No strong sex predilection has been established. The age range is broad, reflecting the association with prior surgical or accidental trauma.[2][13]
- The most common oral sites are the gingiva and alveolar ridge (extraosseous), particularly in areas of prior tooth extraction. The mental foramen region and lower lip are additional recognized sites. Intraosseous lesions are uncommon, with the inferior alveolar nerve canal being the characteristic location when they occur.[2][3][14][15]
Ganglioneuroma
- Ganglioneuroma has an incidence of approximately one per million. The median age at diagnosis is approximately 7 years, though head and neck ganglioneuromas may present in older children and young adults.[7][8][16]
- No significant sex predilection is established (male-to-female ratio approximately 1:1). The most common sites overall are the posterior mediastinum and retroperitoneum; head and neck involvement accounts for a minority of cases. Ganglioneuroma of the mandible is exceedingly rare, with fewer than 10 cases reported as of the most recent literature.[6][7][8][17]
Clinical presentation
Traumatic neuroma
- Presentation: Most oral traumatic neuromas present as small, firm, sessile or pedunculated submucosal nodules, typically less than 1 cm in diameter. A history of prior surgery, tooth extraction, or trauma to the region is characteristic but not always elicited.[2][14]
- Symptoms: Approximately one-third of oral traumatic neuromas are painful, with neuralgic pain, hyperesthesia, or paresthesia being the hallmark symptoms. A localized trigger point that reproduces sharp, shooting pain on palpation is a classic finding. The remaining cases are asymptomatic and discovered incidentally.[1][2][13]
- Red flags: Intraosseous traumatic neuromas of the inferior alveolar nerve may mimic trigeminal neuralgia, presenting with refractory facial pain and mandibular paresthesia without visible intraoral lesions. This diagnostic pitfall can delay appropriate management.[14]
- Tempo: Onset typically follows weeks to months after the inciting trauma, though the interval may be years.[1][14]
Ganglioneuroma
- Ganglioneuroma of the head and neck typically presents as a slow-growing, painless mass. Mandibular ganglioneuroma may cause progressive jaw swelling.[6][7][18]
- Compressive symptoms depend on location and size; cervical ganglioneuromas may produce dysphagia, dysphonia, or Horner syndrome. Functional catecholamine secretion occurs in a minority of cases, potentially causing hypertension.[7][8][16][19]
Radiographic findings
Location and distribution
- Traumatic neuroma: Intraosseous traumatic neuromas characteristically arise within or immediately adjacent to the inferior alveolar nerve canal in the posterior mandible, or at the mental foramen. Extraosseous lesions produce no primary osseous findings on dental radiographs.[3][14]
- Ganglioneuroma: The rare mandibular ganglioneuroma presents as an expansile intraosseous lesion of the mandibular body or ramus.[6]
Periphery and shape
- Intraosseous traumatic neuromas typically appear as small, well-defined or partially defined radiolucent lesions with an oval or fusiform shape. A corticated border may be present but is not a consistent feature. The lesion conforms to the course of the nerve canal.[3][14]
- Mandibular ganglioneuroma may present as a well-defined or partially defined radiolucent lesion; however, the rarity of jaw involvement limits characterization of consistent border features.[6]
Internal architecture
- Traumatic neuromas are characteristically radiolucent without internal calcification or septation.[3][14]
- Ganglioneuromas are predominantly radiolucent when intraosseous. On cross-sectional imaging of non-jaw sites, punctate calcification is an occasional finding.[20]
Effects on adjacent structures
- Intraosseous traumatic neuromas characteristically produce widening of the inferior alveolar nerve canal, which is the most diagnostically useful radiographic sign. This widening is best appreciated on cross-sectional imaging, where the mass can be seen expanding the canal lumen.[3][14]
- Tooth displacement and root resorption are not typical features of traumatic neuroma, helping to distinguish it from true neoplasms.
- Mandibular ganglioneuroma may cause tooth displacement and cortical expansion given its neoplastic growth potential.[6]
Cortical involvement and extent
- Traumatic neuromas are typically small and confined to the nerve canal, with cortical thinning or perforation being uncommon.[3]
- Ganglioneuroma of the mandible may produce cortical expansion and thinning proportional to tumor size.[6]
- Cross-sectional imaging (CBCT) is superior to panoramic radiography for evaluating the spatial relationship between the lesion and the nerve canal, cortical integrity, and three-dimensional extent. Panoramic radiography alone may have limited diagnostic performance for small intraosseous neuromas, particularly at the mental foramen.[14][21]
Recognized variants and diagnostic considerations
- The end-bulb neuroma (stump neuroma) forms at the transected end of a nerve, while the neuroma-in-continuity develops along an injured but non-transected nerve segment. Both may occur in the mandible following surgical trauma.[22]
- Extraosseous traumatic neuromas of the oral soft tissues are radiographically occult on dental imaging and are diagnosed clinically and histopathologically.
Other imaging findings
MRI features
- On MRI, traumatic neuromas appear as fusiform or nodular masses with indistinct margins and no capsule. Signal intensity is typically isointense to slightly hyperintense on T1-weighted images and heterogeneously hyperintense on T2-weighted images. Enhancement after gadolinium administration is common.[23][24]
- The absence of a target sign is a useful discriminator from schwannoma and neurofibroma, which may demonstrate this finding. A tail sign (tapering extension along the parent nerve) is characteristic.[9][23]
- A hypointense rim on T2-weighted images has been described in traumatic neuromas after neck dissection, helping differentiate them from recurrent lymphadenopathy.[24]
MRI of ganglioneuroma
- Ganglioneuromas are typically well-defined, oval masses with low signal on T1-weighted images and marked hyperintensity on T2-weighted images. Dynamic contrast-enhanced MRI characteristically shows a lack of early enhancement with gradual increasing enhancement, reflecting the Schwannian stromal composition. Atypical enhancement patterns should raise concern for a malignant neuroblastic component.[20]
Ultrasound
- On ultrasound, traumatic neuromas appear as hypoechoic, fusiform masses with a central hyperechoic area in some cases, and a low short-axis-to-long-axis ratio distinguishing them from rounded lymph nodes.[24]
Differential diagnosis
Intraosseous neurogenic lesions of the jaws share overlapping radiographic features—well-defined radiolucencies associated with the neurovascular canal—making histopathologic confirmation essential. The key radiographic discriminators center on the relationship to the nerve canal, presence of expansion, internal architecture, and clinical context.
| Entity | Why it is considered | Best discriminator |
|---|---|---|
| Schwannoma (neurilemmoma) | Well-defined unilocular radiolucency in the posterior mandible, often with cortical expansion | Schwannomas typically show greater expansion and may display a target sign on MRI; traumatic neuromas are smaller, conform to the canal, and lack a capsule[23][25][26] |
| Neurofibroma | Unilocular radiolucency of the mandible, occasionally associated with neurofibromatosis type 1 | Neurofibromas tend to be larger with fusiform nerve enlargement; association with NF1 stigmata and mixed S-100 staining pattern distinguish them[12][26][27] |
| Palisaded encapsulated neuroma (solitary circumscribed neuroma) | Submucosal nodule of the palate or face in a middle-aged patient | PEN is a well-circumscribed, encapsulated dermal/mucosal lesion with organized fascicles and a 1:1 axon-to-Schwann cell ratio, unlike the disorganized architecture of traumatic neuroma[28][29][30] |
| Perineural spread of malignancy | Widening of the inferior alveolar canal with associated paresthesia | Progressive numb chin syndrome, irregular canal destruction, and a known primary malignancy distinguish perineural tumor spread from the smooth canal widening of traumatic neuroma[31] |
The highest-risk diagnostic pitfall is misidentifying perineural spread of malignancy as a benign neuroma, particularly in patients with numb chin syndrome and a history of cancer. Any progressive mandibular paresthesia with canal widening warrants biopsy and correlation with oncologic history.
Histopathology
Traumatic neuroma
- The hallmark is a disorganized, haphazard proliferation of nerve fascicles (axons and Schwann cells) embedded in a dense fibrous connective tissue stroma, without encapsulation. This disorganized architecture distinguishes it from true nerve sheath neoplasms.[2][32]
- Inflammatory infiltrate is present in a substantial proportion of cases and is the only histologic feature significantly correlated with pain.[2]
- Immunohistochemistry: S-100 protein highlights Schwann cells within the proliferating nerve fascicles. However, overall S-100 positivity may be weak or patchy compared with schwannoma, owing to the predominance of fibrous tissue. GLUT-1 expression in perineurial cells surrounding the nerve fascicles confirms the reactive nature of the lesion. Neurofilament and neuron-specific enolase (NSE) stain the axonal component.[15][26][32][33][34]
- Pseudoganglioneuroma variant: Mature ganglion cells may be found within traumatic neuromas, particularly in pharyngeal and laryngeal locations, and should not be misinterpreted as true ganglioneuroma.[11]
Ganglioneuroma
- Composed of mature ganglion cells dispersed within abundant Schwannian stroma (Schwannian stroma-dominant pattern). Slight immaturity of ganglion cells is observed in the majority of cases but does not alter the benign classification.[4][5][8]
- MYCN amplification is absent, distinguishing ganglioneuroma from neuroblastoma.[5][8]
- Immunohistochemistry shows strong S-100 positivity in the Schwannian stromal component and synaptophysin/chromogranin positivity in ganglion cells.[35]
Radiologic-pathologic correlation
- The radiolucent, canal-widening pattern of intraosseous traumatic neuroma corresponds to the non-encapsulated proliferation of nerve tissue expanding within the bony canal. The absence of calcification on imaging reflects the purely soft-tissue composition. Ganglioneuroma's occasional punctate calcification on imaging corresponds to calcified foci within the Schwannian stroma.[3][20]
Management and prognosis
Traumatic neuroma
- Symptomatic lesions: Surgical excision is the primary treatment for painful traumatic neuromas. Nerve-sparing excisional biopsy is preferred when feasible, particularly for lesions involving the inferior alveolar nerve, to preserve sensory function.[1][3]
- Conservative management: For patients with mild symptoms or those who are poor surgical candidates, topical anesthetic therapy (e.g., lidocaine gel applied via a custom neurosensory stent) may provide sustained pain relief.[13]
- Surgical technique considerations: Excision with direct neurorrhaphy (with or without nerve grafting) is associated with lower reoperation rates compared with simple excision or excision with implantation into muscle or bone.[36]
- Asymptomatic lesions: Incidentally discovered, asymptomatic traumatic neuromas may be observed if the diagnosis is confirmed, as they carry no malignant potential.[2]
- Prognosis: Recurrence after complete excision is uncommon. There is no risk of malignant transformation.[3][14]
Ganglioneuroma
- Treatment: Complete surgical excision is the standard of care. For mandibular ganglioneuroma, segmental resection with immediate reconstruction (e.g., free fibula flap) may be required depending on tumor size.[6][7][37]
- Prognosis: Outcomes are excellent, with overall survival rates of 96–100%. Even with incomplete resection, tumor progression is rarely observed. Postoperative neurological complications (e.g., Horner syndrome for cervical lesions) are the primary source of morbidity.[5][7][8][19]
- Surveillance: Long-term follow-up is recommended given the theoretical potential for regional lymph node involvement, though distant metastasis and recurrence are exceedingly rare.[8][17]
Special considerations
Multiple endocrine neoplasia type 2B (MEN 2B)
- Multiple mucosal neuromas of the lips, tongue, and oral mucosa are an early and characteristic feature of MEN 2B syndrome (associated with RET proto-oncogene mutations), and must be distinguished from solitary traumatic neuroma. MEN 2B-associated mucosal neuromas present in childhood, are multiple, and are accompanied by medullary thyroid carcinoma and pheochromocytoma.[15][38]
- A solitary oral traumatic neuroma with a clear history of antecedent trauma does not warrant MEN 2B workup. However, multiple oral neuromas without a traumatic etiology, particularly in a young patient, should prompt evaluation for MEN 2B.[15][38]
Neurofibromatosis type 1
- Intraosseous neurofibromas of the mandible, though rare, occur in patients with NF1 and may radiographically mimic traumatic neuroma or other intraosseous neurogenic lesions. Clinical stigmata of NF1 (café-au-lait macules, cutaneous neurofibromas, Lisch nodules) should be assessed when an intraosseous neurogenic lesion is identified in a young patient.[12][27]